Introduction
Up to half of all antibiotic use is unnecessary or inappropriate: antibiotics for viral infections, wrong drug, dose or duration, sales without prescription. This drives resistance, adverse reactions and cost. The minimum goal of antimicrobial therapy is clinical cure and prevention of complications at a reasonable cost; the maximum goal adds eradication of the pathogen.
Types of therapy
- Empirical (≈ 75% of cases): started before the pathogen is known, based on the likely organisms at that site; in about half of cases no pathogen is ever found.
- Targeted (aetiological): guided by culture and sensitivity (results take 36–48 h); switch to the narrowest effective drug (de-escalation).
- Prophylactic: e.g. surgical prophylaxis.
Efficacy criteria
- Spectrum and potency: the pathogen must be susceptible; the MIC (minimal inhibitory concentration; MIC₉₀ inhibits 90% of strains) should be low. Susceptibility is reported as S (susceptible), I (susceptible, increased exposure) or R (resistant).
- Pharmacokinetics: the drug must reach the site of infection at concentrations above the MIC (e.g. CSF, bone, prostate, urine).
- PK/PD target, which decides the dosing regimen:
- Bactericidal (β-lactams, aminoglycosides, quinolones, glycopeptides, co-trimoxazole) is preferred in severe infections and in the immunocompromised; bacteriostatic (macrolides, tetracyclines, sulfonamides) relies on host defences.
- Duration: as short as effective (e.g. 3 days for uncomplicated cystitis in women with some agents, 5–7 days for most community-acquired pneumonia).